UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors

Journal of Nuclear Medicine, 2018-01, Vol.59 (1), p.66-74

2018

Link zum Volltext

Verfügbarkeit prüfen

Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case–Control Study

Annals of surgical oncology, 2016-04, Vol.23 (4), p.1361-1370

2016

Link zum Volltext

Verfügbarkeit prüfen

Multicenter phase 2 trial of nintedanib in advanced nonpancreatic neuroendocrine tumors

Cancer, 2020-08, Vol.126 (16), p.3689-3697

2020

Link zum Volltext

Verfügbarkeit prüfen

Predicting malignancy in patients with adrenal tumors using 18F‐FDG‐PET/CT SUVmax

Journal of surgical oncology, 2020-12, Vol.122 (8), p.1821-1826

2020

Link zum Volltext

Verfügbarkeit prüfen

Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document

Gynecologic oncology, 2011-07, Vol.122 (1), p.190-198

2011

Link zum Volltext

Verfügbarkeit prüfen

Association Between Remote Monitoring and Acute Care Visits in High-Risk Patients Initiating Intravenous Antineoplastic Therapy

JCO oncology practice, 2022-12, Vol.18 (12), p.e1935-e1942

2022

Link zum Volltext

Verfügbarkeit prüfen

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

Journal of clinical oncology, 2023-03, Vol.41 (7), p.1359-1369

2023

Link zum Volltext

Verfügbarkeit prüfen

The Management of Extrapulmonary Poorly Differentiated (High-Grade) Neuroendocrine Carcinomas

Seminars in oncology, 2013-02, Vol.40 (1), p.100-108

2013

Link zum Volltext

Verfügbarkeit prüfen

Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumors

Annals of surgical oncology, 2024-04, Vol.31 (4), p.2337-2348

2024

Link zum Volltext

Verfügbarkeit prüfen

Early-Onset Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathology Features, and Oncological Outcomes

Annals of surgery, 2024-01, Vol.279 (1), p.125

2024

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma

Journal of hepatology, 2014-02, Vol.60 (2), p.319-324

2014

Link zum Volltext

Verfügbarkeit prüfen

Recurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence and Current Treatment

Annals of surgery, 2023-11, Vol.278 (5), p.e1063

2023

Link zum Volltext

Verfügbarkeit prüfen

Systemic Therapies for Advanced Pancreatic Neuroendocrine Tumors

Hematology/oncology clinics of North America, 2016-02, Vol.30 (1), p.119-133

2016

Link zum Volltext

Verfügbarkeit prüfen

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting

JNCI : Journal of the National Cancer Institute, 2023-09, Vol.115 (9), p.1001-1010

2023

Link zum Volltext

Verfügbarkeit prüfen

Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?

Journal of Nuclear Medicine, 2020-08, Vol.61 (8), p.1094-1095

2020

Link zum Volltext

Verfügbarkeit prüfen

Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms

Pancreas, 2021-02, Vol.50 (2), p.138

2021

Link zum Volltext

Verfügbarkeit prüfen

Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition

PloS one, 2019-06, Vol.14 (6), p.e0217399

2019

Link zum Volltext

Verfügbarkeit prüfen

Reply to 'H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines'

Nature genetics, 2019-10, Vol.51 (10), p.1427-1428

2019

Link zum Volltext

Verfügbarkeit prüfen

NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy

The Journal of nuclear medicine (1978), 2020-02, Vol.61 (2), p.222-227

2020

Link zum Volltext

Verfügbarkeit prüfen

NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177 Lu-DOTATATE Peptide Receptor Radionuclide Therapy

Journal of Nuclear Medicine, 2020-02, Vol.61 (2), p.222-227

2020

Link zum Volltext

Verfügbarkeit prüfen

Predicting malignancy in patients with adrenal tumors using 18 F-FDG-PET/CT SUVmax

Journal of surgical oncology, 2020-12, Vol.122 (8), p.1821-1826

2020

Link zum Volltext

Verfügbarkeit prüfen

Cancer Clinical Trials in Africa-An Untapped Opportunity: Recommendations From AORTIC 2019 Conference Special Interest Group in Clinical Trials

JCO global oncology, 2021-12, Vol.7 (7), p.1358-1363

2021

Link zum Volltext

Verfügbarkeit prüfen

Systemic therapy for advanced pancreatic neuroendocrine tumors: an update

Journal of the National Comprehensive Cancer Network, 2012-06, Vol.10 (6), p.777

Reidy-Lagunes, Diane L

2012

Link zum Volltext

Verfügbarkeit prüfen

Targeted Therapies in Neuroendocrine Tumors (NET): Clinical Trial Challenges and Lessons Learned

The oncologist (Dayton, Ohio), 2013-05, Vol.18 (5), p.525-532

2013

Link zum Volltext

Verfügbarkeit prüfen

Oncology Patients' Perspectives on Remote Patient Monitoring for COVID-19

JCO oncology practice, 2021-09, Vol.17 (9), p.e1278-e1285

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 102

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)

Publikationsform

Artikel
(101)
Buchkapitel
(1)

Sprache

Englisch
(102)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(58)
Humans
(54)
Oncology
(39)
Neuroendocrine Tumors
(30)
Tumors
(18)
Neuroendocrine Tumors - Drug Therapy
(17)
Neuroendocrine Tumors - Pathology
(15)
Male
(14)
Female
(13)
Patients
(13)
Medicine
(12)
Middle Aged
(12)
Pancreatic Neoplasms - Drug Therapy
(11)
Surgery
(11)
Cancer
(10)
Retrospective Studies
(10)
Aged
(9)
Medicine & Public Health
(9)
Metastases
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors

Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case–Control Study

Multicenter phase 2 trial of nintedanib in advanced nonpancreatic neuroendocrine tumors

Predicting malignancy in patients with adrenal tumors using 18F‐FDG‐PET/CT SUVmax

Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document

Association Between Remote Monitoring and Acute Care Visits in High-Risk Patients Initiating Intravenous Antineoplastic Therapy

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

The Management of Extrapulmonary Poorly Differentiated (High-Grade) Neuroendocrine Carcinomas

Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumors

Early-Onset Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathology Features, and Oncological Outcomes

A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma

Recurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence and Current Treatment

Systemic Therapies for Advanced Pancreatic Neuroendocrine Tumors

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting

Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?

Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms

Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition

Reply to 'H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines'

NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy

NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177 Lu-DOTATATE Peptide Receptor Radionuclide Therapy

Predicting malignancy in patients with adrenal tumors using 18 F-FDG-PET/CT SUVmax

Cancer Clinical Trials in Africa-An Untapped Opportunity: Recommendations From AORTIC 2019 Conference Special Interest Group in Clinical Trials

Systemic therapy for advanced pancreatic neuroendocrine tumors: an update

Targeted Therapies in Neuroendocrine Tumors (NET): Clinical Trial Challenges and Lessons Learned

Oncology Patients' Perspectives on Remote Patient Monitoring for COVID-19

Aktive Filter

Suchergebnisse filtern